Nasopharyngeal Carcinoma (NPC) Clinical Trials in Guangzhou, Guangdong
5 recruitingGuangzhou, Guangdong, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen456 enrolled12 locationsNCT07328841
Recruiting
Phase 2
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech70 enrolled15 locationsNCT06839066
Recruiting
Phase 3
Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University466 enrolled1 locationNCT06712888
Recruiting
Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection
Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital, Sun Yat-Sen University700 enrolled1 locationNCT06763289
Recruiting
Phase 1
Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University24 enrolled1 locationNCT06611150